Skip to content

Alpha Way: value indication

Roughly what is an SME worth on what it filed? A range from its adjusted equity and its earnings, with your own assumptions, recalculated as you go.

Value indication

Alpha Way

BE 0807.204.603
NACE 43.990, Other specialised construction activities
latest balance sheet 31-12-2024indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€306,552 to €361,555

Midpoint €329,470 · 50% capitalised earnings, 50% adjusted equity

Adjusted equity €338,089
Capitalised earnings €275,014 to €385,020
Indication €306,552 to €361,555

Your assumptions

Capitalised earnings
%

The return a buyer expects on the money put in. Higher for more risk. The range also computes with 2 points more and less.

Adjust the equity
Blend
50%
Optional: your own multiple

Checked holds no market prices, so it suggests no multiple. If you have one from a transaction or a study, the tool applies it to the filed EBITDA less the net financial debt.

Adjusted equity

balance sheet 31-12-2024
Equity (10/15)
€338,089
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€338,089

Capitalised earnings

net result for the year (9904)
2024
€6,723
2023
€53,936
2022
€54,847
2021
€46,018
2020
€4,944
Average result
€38,502
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€275,014 / €320,850 / €385,020

What this indication leaves out

  • Market prices and comparable transactions: Checked does not hold them.
  • Anything after the latest accounts, and items off the balance sheet (guarantees, leases, disputes).
  • The real value of buildings, stock and receivables: enter your own revaluation or adjustment.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale.

For a valuation to decide on: a company auditor or a certified accountant.

Source: filed annual accounts (NBB), latest balance sheet at 31 December 2024. Prepared on 28 September 2026 via checked.be. Indication, not a valuation or advice.